Becker's Healthcare June 10, 2024
On June 10, Moderna said its experimental combination vaccine for COVID-19 and influenza surpassed the efficacy of existing shots in a phase 3 trial.
The company is the first to announce positive late-stage results for a combo flu and COVID-19 vaccine, according to a news release from the drugmaker.
The ongoing phase 3 study is testing the investigational shot against Sanofi’s flu shot, Fluzone HD, and Moderna’s COVID-19 vaccine, Spikevax, among patients 65 and older. Another cohort of adults aged 50 to 64 are either receiving the vaccine candidate or GlaxoSmithKline’s...
Today's Sponsors
Today's Sponsor